Literature DB >> 27979885

Introduction.

.   

Abstract

Year:  2017        PMID： 27979885     DOI： 10.2337/dc17-S001

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  12 in total

Review 1.  Evaluation of the Risk Factors for Type 2 Diabetes Using the Generalized Structure Equation Modeling in Iranian Adults based on Shahedieh Cohort Study.

Authors:  Marzieh Farhadipour; Hossien Fallahzadeh; Akram Ghadiri-Anari; Masoud Mirzaei
Journal:  J Diabetes Metab Disord       Date:  2022-02-16

2.  Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Bethany Warren; Andreea M Rawlings; Alexandra K Lee; Morgan Grams; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2017-05-15       Impact factor: 19.112

3.  Variations in diabetes remission rates after bariatric surgery in Spanish adults according to the use of different diagnostic criteria for diabetes.

Authors:  María R Alhambra-Expósito; María J Molina-Puerta; María I Prior-Sánchez; Gregorio Manzano-García; Alfonso Calañas-Continente; María A Gálvez-Moreno
Journal:  BMC Endocr Disord       Date:  2017-08-15       Impact factor: 2.763

4.  A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.

Authors:  Sultan Linjawi; Byung-Wan Lee; Ömür Tabak; Susanna Lövdahl; Shanti Werther; Salahedeen Abusnana
Journal:  Diabetes Ther       Date:  2017-11-11       Impact factor: 2.945

5.  Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis.

Authors:  Yuli Cai; Tianshu Zeng; Zhongyuan Wen; Lulu Chen
Journal:  Diabetes Ther       Date:  2017-12-20       Impact factor: 2.945

6.  Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.

Authors:  Lawrence Blonde; Denis Raccah; Elisheva Lew; Juliana Meyers; Elena Nikonova; Mayank Ajmera; Keith L Davis; Monica Bertolini; Bruno Guerci
Journal:  Diabetes Ther       Date:  2018-04-19       Impact factor: 2.945

7.  iGlarLixi Reduces Glycated Hemoglobin to a Greater Extent Than Basal Insulin Regardless of Levels at Screening: Post Hoc Analysis of LixiLan-L.

Authors:  Elisabeth Niemoeller; Elisabeth Souhami; Yujun Wu; Klaus H Jensen
Journal:  Diabetes Ther       Date:  2017-11-16       Impact factor: 2.945

8.  Longitudinal Trend of Fasting Blood Glucose and Related Factors in Patients with Type 2 Diabetes.

Authors:  Zahra Khatirnamani; Enayatollah Bakhshi; Arash Naghipour; Robab Teymouri; Samaneh Hosseinzadeh
Journal:  Int J Prev Med       Date:  2020-11-26

9.  Factors associated with self-care practice among adult diabetes patients in West Shoa Zone, Oromia Regional State, Ethiopia.

Authors:  Yonas Gurmu; Debela Gela; Fekadu Aga
Journal:  BMC Health Serv Res       Date:  2018-09-24       Impact factor: 2.655

10.  Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial.

Authors:  Arihiro Kiyosue; Yutaka Seino; Keiji Nishijima; Heidrun Bosch-Traberg; Kohei Kaku
Journal:  J Diabetes Investig       Date:  2017-11-24       Impact factor: 4.232
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.